AMI Asset Management’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Sell
19,398
-731
-4% -$47.8K 0.08% 40
2026
Q1
$1.36M Sell
20,129
-21,080
-51% -$1.19M 0.09% 40
2025
Q4
$1.71M Sell
41,209
-2,911
-7% -$120K 0.1% 39
2025
Q3
$1.78M Buy
44,120
+5,641
+15% +$164K 0.1% 40
2025
Q2
$1M Buy
+38,479
New +$927K 0.06% 53

Other funds holding CGON

AMI Asset Management's CGON Position: Q2 2026 in Review

AMI Asset Management reduced its CG Oncology (CGON) stake by 3.6% in Q2 2026, selling an estimated $47.8K and leaving 19,398 shares worth $1.38M. The position accounts for 0.08% of the portfolio, ranked #40.

AMI Asset Management first reported a position in CGON in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.78M in Q3 2025. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • AMI Asset Management held 19,398 shares of CG Oncology worth $1.38M as of Q2 2026.
  • AMI Asset Management sold 731 CG Oncology shares in Q2 2026, an estimated $47.8K.
  • CG Oncology made up 0.08% of AMI Asset Management's portfolio in Q2 2026, its #40 holding.
  • AMI Asset Management first reported a position in CG Oncology in Q2 2025 and has held it in 5 quarters since.
  • AMI Asset Management's CG Oncology position peaked at $1.78M in Q3 2025.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on AMI Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.